Pharma Industry Sees Apprenticeship As Platform To Spot Young Talent Hunt To Strengthen Workforce

Bengaluru : Indian pharma industry now sees the Union government’s mandatory apprenticeship programmes as a platform to spot the young qualified talent to strengthen its workforce.  The country’s apprenticeship engagement is witnessing a positive engagement trend.

Currently, overall apprenticeship count has surpassed 5 lakh driven by awareness, ease of doing apprenticeships, good experience and government providing subsidy. A similar positive trend prevails in the pharma sector as well. Overall, a net increase of 55% is expected in apprenticeship deployment in pharma in the first half of the calendar year.

The credit based degree apprenticeship program under the New Educational Policy 2020 emphasizes job training leading to high employability making these student apprentices most sought-after resources.

According to Kaushik Desai, advisor, Indian Pharma Machine Manufacturers’ Association (IPMMA), apprenticeship period gives an opportunity to companies and as well as candidates to understand the nature of the job and decide their future course of action to choose a  career progression. The pharmaceutical companies should make best utilization of this scheme to train, develop and identify the right person for the right job.

Chiming in on a similar note was Sunil Attavar, former president, Karnataka Drugs and Pharmaceutical Manufacturers Association (KDPMA) who said that considerable importance to recruit apprenices under the National apprentice programme scheme supported by the LSSSDC is evident.

KDPMA too, encourages the need to employ apprentices. The big advantages being hands on training to a fresh pharmacy talent pool. From an industry perspective, it is identifying qualified pharmacy graduates or post graduates who could spur innovation which is much-desired by the sector, he added.

Sumit Kumar, chief business officer, TeamLease Education Foundation, stated, “We are at the brink of apprenticeship expansion as organisations over a period of time have realised the merits of doing apprenticeship which has raised the confidence of the employer.

Also, the favourable macro-economic factors are expected to deliver a sectoral growth of 37% CAGR till 2025. Low production with research and development cost have led to spike in exports, followed by production linked incentive (PLI), increase in insurance to push for medical expenditure and increase in FDI (foreign direct investment) are the growth drivers for the sector.

Pharma is looking at a talent strategy across board on account of demand for skilled workforce which is leading to a wider acceptance of apprenticeship. In order to cater to the demand, companies have opened gates for 12th pass outs and technical diploma holders for production roles, largely dominated by ITI trainees. Interestingly, companies fulfill the diversity agenda through apprenticeships. Production job roles which have been traditionally dominated by males are now executed by women and 28% of the latter are expected to be engaged in apprenticeships, Kumar told Pharmabiz.

Industry is partnering with academia to create programmes which makes apprenticeships aspirational and organisations are able to tackle the talent crunch at the grass root level. Such partnerships will see courses curated and offered for apprentice numbers to go up by at least 10 times. Apprenticeships have proven to be the viable mechanism to create talent and but degree apprenticeships will create the talent supply chain which is the much needed investment to overcome skill crisis and up productivity. Third Party Administrator (TPAs) facilitated apprenticeships for SMEs by offering training and other ancillary services, stated Kumar.

  • Related Posts

    Eli Lilly launches cancer drug Tanstrive in India

    New Delhi: Eli Lilly and Company India on Thursday announced the launch of its cancer treatment drug Tanstrive in India. The launch follows marketing authorisation from the Central Drugs Standard Control Organisation…

    Centre eases BIS quality compliance with new risk-based framework for manufacturers

    The Centre has introduced a risk-based compliance mechanism to ease industry compliance with Quality Control Orders (QCOs), allowing eligible manufacturers to follow a simplified certification route while maintaining product quality…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Eli Lilly launches cancer drug Tanstrive in India

    Eli Lilly launches cancer drug Tanstrive in India

    Sir Ganga Ram Hospital excels in Medical Research among Private Hospitals

    Sir Ganga Ram Hospital excels in Medical Research among Private Hospitals

    Centre eases BIS quality compliance with new risk-based framework for manufacturers

    Centre eases BIS quality compliance with new risk-based framework for manufacturers

    SS Innovations International aces Race beating Global Giants in Surgical Robotics

    SS Innovations International aces Race beating Global Giants in Surgical Robotics

    ‘SHE’ comes all the Way from Calcutta to Delhi to Care for Women’s Fertility

    ‘SHE’ comes all the Way from Calcutta to Delhi to Care for Women’s Fertility

    India curbs supply of IVF consumables to unregistered clinics

    India curbs supply of IVF consumables to unregistered clinics